Refine
Has Fulltext
- yes (34)
Is part of the Bibliography
- yes (34)
Year of publication
Document Type
- Journal article (34)
Language
- English (34)
Keywords
- in vitro (3)
- tissue engineering (3)
- Neisseria gonorrhoeae (2)
- bioengineering (2)
- collagens (2)
- extracellular matrix (2)
- gene expression (2)
- inflammation (2)
- stem cells (2)
- 1st-line treatment (1)
- 3D in vitro models (1)
- 3D tissue model (1)
- 3D tissue models (1)
- 5-Fluorouracil (1)
- Alternative test methods (1)
- Articular-Cartilage (1)
- Assay (1)
- BRAF mutation (1)
- Beta-catenin (1)
- BioVaSc (1)
- Biomechanical Properties (1)
- Biomedical engineering (1)
- CYP induction (1)
- CYP inhibition (1)
- Carcinoma cells (1)
- Cardiac ventricles (1)
- Chemicals (1)
- Collagen (1)
- Compressive Properties (1)
- Data acquisition (1)
- Diffusion tensor imaging (1)
- Draize eye test (1)
- Eigenvectors (1)
- Episkin (1)
- Fibroblasts (1)
- Fluorouracil (1)
- Heart (1)
- Human Knee (1)
- Human Medial Meniscus (1)
- In vitro skin irritation testing (1)
- Injuries (1)
- Invasion (1)
- Magnetic resonance imaging (1)
- Matrix (1)
- Model (1)
- Models (1)
- Multicenter randomized-trial (1)
- OECD guideline (1)
- Open source reconstructed epidermis (1)
- Osteoarthritis (1)
- RHE (1)
- Repair (1)
- Salmonella (1)
- Stem-cell biotechnology (1)
- Swine (1)
- Tissue (1)
- Tractography (1)
- Triple co-culture (1)
- Validation (1)
- Vivo (1)
- adenocarcinoma of the lung (1)
- adhesion (1)
- adults (1)
- air-liquid interface (1)
- albumins (1)
- algorithm (1)
- alternative to animal testing (1)
- alternatives (1)
- anatomy (1)
- antennas (1)
- artificial membrane-permeability (1)
- asthmatic bronchial epithelium (1)
- astrocytes (1)
- autologous chondrocyte implantation (1)
- bioinformatics (1)
- biological models (1)
- biomaterial tests (1)
- biomedical engineering (1)
- biomimetic 3D tissue model (1)
- bioreactor (1)
- bioreactor culture (1)
- biotechnology (1)
- blood-brain barrier (BBB) model (1)
- calcium fluoride nanoparticles (1)
- cancer treatment (1)
- cartilage repair (1)
- cell culture (1)
- cell engineering (1)
- cellular biology (1)
- cellular microenvironment (1)
- central nervous system (1)
- co-culture (1)
- colony-stimulating factor (1)
- colorectal cancer (1)
- combination of physical vapor deposition and electrochemical etching (1)
- combinatorial drug predictions (1)
- core depression (1)
- corneal equivalent (1)
- critical size defect (1)
- culture techniques (1)
- cultured (1)
- cytokines (1)
- cytotoxicity (1)
- decellularization (1)
- defined humanized test system (1)
- drug metabolism (1)
- dynamic culture conditions (1)
- early diagnosis (1)
- embryonic stem cells (1)
- enzyme metabolism (1)
- epidermis (1)
- epithelial cell culture (1)
- epithelial cells (1)
- equipment and supplies (1)
- establishment (1)
- ex vivo model (1)
- experimental models of disease (1)
- expression (1)
- eye irritation testing (1)
- factor-VIII (1)
- fibroblast chemotaxis (1)
- foreign body reaction (1)
- gastrointestinal tract (1)
- gels (1)
- gene therapy (1)
- heptaocytes (1)
- host (1)
- human (1)
- human heptocytes (1)
- human induced pluripotent stem cells (hiPSCs)human induced pluripotent stem cells (hiPSCs) (1)
- immunotherapeutics (1)
- immunotherapies (1)
- in silico simulation (1)
- in situ guided tissue regeneration (1)
- in vitro models (1)
- in vivo (1)
- induction (1)
- infection (1)
- infectious disease (1)
- inflammation-induced tissue demage (1)
- inflammatory bowel disease (1)
- inflammatory response (1)
- invasion (1)
- invasiveness (1)
- label-free analysis (1)
- living cells (1)
- lncRNAs (1)
- lung and intrathoracic tumors (1)
- lung cancer (1)
- magnetic resonance imaging (MRI) (1)
- mechanisms of disease (1)
- medicine (1)
- mesenchymal cells (1)
- mesenchymal stem cells (1)
- mesenchymal tissues (1)
- miRNAs (1)
- microenvironment (1)
- microwave radiation (1)
- modular tumor tissue models (1)
- molecular biology (1)
- multifunctional nanoparticles (1)
- multimodal imaging (1)
- multipotent fetal neural stem cells (fNSCs) (1)
- murine (1)
- nanotopographical surfaces (1)
- neurovascular unit in vitro (1)
- neutrophil transmigration (1)
- non-invasive biomarkers (1)
- on-a-chip (1)
- oragnoids (1)
- osteochondral allografts (1)
- osteochondral biopsy (1)
- osteogenesis imperfecta (1)
- outgrowth endothelial cells (1)
- parasitology (1)
- perfusion-based bioreactor system (1)
- permeability (1)
- phenotype (1)
- photoluminescence (1)
- physiology (1)
- primary cell isolation (1)
- primary cells (1)
- progenitor cells (1)
- pulmonary drug-delivery (1)
- pulmonary imaging (1)
- quanititative characterization (1)
- quantification (1)
- raman spectroscopy (1)
- real time PCR (1)
- reconstructed human epidermis (1)
- reflection (1)
- regenerative medicine (1)
- replacement (1)
- respiratory syncytial virus (1)
- responses (1)
- scaffolds (1)
- secondary lung tumors (1)
- segmental collapse (1)
- sheep model (1)
- skin anatomy (1)
- skin equivalents (1)
- skin physiology (1)
- small intestinal submucosa scaffold (1)
- stratification (1)
- stromal cells (1)
- systemic inflammatory response syndrome (1)
- targeted therapy (1)
- tissue remodeling (1)
- trachea (1)
- transcriptomics (1)
- translational research (1)
- translocation (1)
- transport studies (1)
- tumor cells (1)
- tumor test system (1)
- upcyte hepatocytes (1)
- vascularization (1)
- vesicle-based barrier (1)
- virulence (1)
- xenotransplantation (1)
Institute
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (34)
- Theodor-Boveri-Institut für Biowissenschaften (8)
- Institut für Molekulare Infektionsbiologie (3)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (3)
- Frauenklinik und Poliklinik (2)
- Lehrstuhl für Orthopädie (2)
- Medizinische Klinik und Poliklinik II (2)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (1)
- Augenklinik und Poliklinik (1)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
Sonstige beteiligte Institutionen
To improve and focus preclinical testing, we combine tumor models based on a decellularized tissue matrix with bioinformatics to stratify tumors according to stage-specific mutations that are linked to central cancer pathways. We generated tissue models with BRAF-mutant colorectal cancer (CRC) cells (HROC24 and HROC87) and compared treatment responses to two-dimensional (2D) cultures and xenografts. As the BRAF inhibitor vemurafenib is—in contrast to melanoma—not effective in CRC, we combined it with the EGFR inhibitor gefitinib. In general, our 3D models showed higher chemoresistance and in contrast to 2D a more active HGFR after gefitinib and combination-therapy. In xenograft models murine HGF could not activate the human HGFR, stressing the importance of the human microenvironment. In order to stratify patient groups for targeted treatment options in CRC, an in silico topology with different stages including mutations and changes in common signaling pathways was developed. We applied the established topology for in silico simulations to predict new therapeutic options for BRAF-mutated CRC patients in advanced stages. Our in silico tool connects genome information with a deeper understanding of tumor engines in clinically relevant signaling networks which goes beyond the consideration of single drivers to improve CRC patient stratification.